MRNA

Moderna, Inc. (MRNA)

Last Price$35.55.3%
Market Cap$13.7B
LTM Gross margin
52.3%
5Y avg
(153.2%)
Biotechnology industry median
66.6%
Stock quality & Intrinsic value
6/10
0.9% undervalued

Moderna, Inc. Gross margin

Annual
Quarterly
LTM
Industry median
Company stand-alone
MRNA
Healthcare
Crunching data... Almost there!
Dec'16Dec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23
Gross margin
85.1%
88.4%
(270.6%)
35.4%
97.1%
85.2%
71.9%
31.5%
MRNA
Key metrics and insights to make informed decisions.
View full analysis
Overvalued or undervalued?
Check the intrinsic value for MRNA and see if it's the right time to invest.
Dive in

Moderna, Inc. (MRNA) Gross margin comparison analysis

Crunching data... Almost there!

MRNA key stats

USD
Millions
Billions
Annual
Quarterly
Trailing
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
Crunching data... Almost there!

Discover more Stock Ideas

FAQ

1) What is Moderna, Inc.'s Gross margin?

As of today, Microsoft Corp's last 12-month Gross margin is 52.3%, based on the financial report for Dec 31, 2024 (Q4 2024). The average annual Gross margin for Moderna, Inc. have been 61.8% over the past three years, and (160.9%) over the past five years.

2) Is Moderna, Inc.'s Gross margin Good?

As of today, Moderna, Inc.'s Gross margin is 52.3%, which is lower than industry median of 66.6%. It indicates that Moderna, Inc.'s Gross margin is Bad.

3) How does Moderna, Inc.'s Gross margin compare to its peers?

As of today, Moderna, Inc.'s Gross margin is 52.3%, which is lower than peer median of 86.4%. The list of peers includes SMMT, INCY, UTHR, ARGX, REGN, VRTX, ALNY, NVO, BNTX, BGNE.